Your browser doesn't support javascript.
loading
Respuesta de los autores: La atropina superdiluida al 0.01% frena el aumento de miopía en niños-adolescentes. Un estudio a largo plazo 5 años de evolución: seguridad y eficacia / Author's reply: Superdiluted atropine at 0.01% reduces myopia progression in children and adolescents. A 5-year study of safety and effectiveness
Díaz Llopis, M.
Affiliation
  • Díaz Llopis, M; Universidad de Valencia. Hospital La Fe. Valencia. España
Arch. Soc. Esp. Oftalmol ; 94(3): e20-e20, mar. 2019.
Article in Spanish | IBECS | ID: ibc-178321
Responsible library: ES1.1
Localization: BNCS
RESUMEN
No disponible
Subject(s)
Search on Google
Add to My VHL
Print
XML

Collection: National databases / Spain Database: IBECS Main subject: Atropine / Contact Lenses / Eyeglasses / Myopia Limits: Adolescent / Child / Humans Language: Spanish Journal: Arch. Soc. Esp. Oftalmol Year: 2019 Document type: Article Institution/Affiliation country: Universidad de Valencia/España
Search on Google
Add to My VHL
Print
XML

Collection: National databases / Spain Database: IBECS Main subject: Atropine / Contact Lenses / Eyeglasses / Myopia Limits: Adolescent / Child / Humans Language: Spanish Journal: Arch. Soc. Esp. Oftalmol Year: 2019 Document type: Article Institution/Affiliation country: Universidad de Valencia/España